Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraarterial Verapamil in Ischemic Stroke
NCT03347786Phase 2Recruiting
- Sponsor
- Global Neurosciences Institute
- Start
- Apr 2017
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of verapamil in ischemic stroke, sponsored by Global Neurosciences Institute. Started Apr 2017; status: recruiting.
02
Drugs
verapamil
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03347786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03347786.